Skip to main content
. 2021 Jan 13;31(2):489–494. doi: 10.1007/s40670-020-01190-x

Table 2.

Responses to true/false knowledge items

True N (%) False N (%) Don’t know N (%)
Drug prices in the USA are about the same as prices in other developed countries. 2 (1.0) 228 (94.7) 10 (4.2)
Drug PRICES in the USA are rising faster than inflation. 204 (84.8) 5 (2.1) 31 (12.9)
US drug SPENDING is rising less than other health care spending. 28 (11.9) 137 (56.8) 75 (31.3)
Drug prices are NOT correlated with effectiveness. 199 (82.7) 10 (4.1) 31 (12.9)
Drug prices are correlated with research and development costs. 92 (38.3) 106 (44.0) 42 (17.5)
The rise in US drug SPENDING is driven more by increased utilization than by higher prices. 24 (9.9) 146 (60.5) 70 (29.2)
Drugs with higher retail prices always cost health plans more than drugs with lower retail prices. 30 (12.8) 114 (46.9) 96 (40.0)
When administering intravenous drugs to patients in clinics, physicians receive higher payments from insurers if they use lower-priced, more cost-effective drugs. 39 (16.1) 79 (32.5) 122 (50.1)

Italic emphasis indicates correct responses, as determined by content experts